Skip to main content
SP5007,798.99+0.65%DOW53,839.99+0.13%NASDAQ26,803.03+0.81%BTC$62,819.00-0.97%ETH$1,875.51-0.03%GOLD$4,407.10-0.30%OIL$81.72+0.58%
Smart Investors Daily
Sign InSign Up Free
AxoGen, Inc. logo

NASDAQ · AXGN

AxoGen, Inc.

Healthcare · Medical - Devices

$48.05

Down-$1.62 (-3.26%)

Updated Aug 14, 2026, 11:28 AM

SID Score

6.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.38B
P/E ratio
-656.51
Dividend yield
0.00%
52-week range
$27.54 – $49.90
Volume
760.45K
Avg. volume
1.09M

Price performance

AXGN price history

1M range · 21 trading sessions · Daily adjusted prices

AXGN closed at $48.05 after 21 trading sessions, up 20.80% for the selected period.

Last close
$48.05
Period change
+20.80%
Period low
$39.37
Period high
$49.67
Daily close
View OHLC price history
AXGN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$49.20$49.929$47.59$48.05760.45K
Aug 12, 2026$48.50$49.90$48.26$49.67716.48K
Aug 11, 2026$48.21$49.12$47.31$48.48576.93K
Aug 10, 2026$46.03$48.72$45.95$48.22978.34K
Aug 7, 2026$44.75$46.54$44.415$46.43713K
Aug 6, 2026$45.07$45.615$44.11$44.35550.94K
Aug 5, 2026$45.59$45.59$44.2501$45.22968.88K
Aug 4, 2026$45.89$46.75$45.01$45.961.13M
Aug 3, 2026$42.78$46.12$42.525$45.731.4M
Jul 31, 2026$40.99$42.78$39.92$42.211.22M
Jul 30, 2026$40.81$44.76$40.81$41.351.39M
Jul 29, 2026$38.31$46.15$38.31$41.372.51M
Jul 28, 2026$41.605$42.035$39.785$41.151.37M
Jul 27, 2026$39.77$41.27$39.605$41.14971.24K
Jul 24, 2026$40.01$40.645$39.35$39.49750.55K
Jul 23, 2026$38.67$39.81$38.38$39.73851.4K
Jul 22, 2026$39.66$40.10$38.69$39.37982.99K
Jul 21, 2026$40.07$40.87$39.56$40.261.24M
Jul 20, 2026$39.77$40.70$39.12$39.481.06M
Jul 17, 2026$38.85$39.90$38.44$39.851.2M
Jul 16, 2026$38.67$40.575$38.41$39.7751.32M

Latest AXGN news

The latest Smart Investors Daily articles mentioning AXGN.

Stock researchCompany · Overview

AXGN research

Overview

Company profile and research snapshot.

Company profile

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$37.43
Implied upside
—
Analysts
—
AXGN recent ratings
DateFirmRatingTarget
Jul 30, 2026Canaccord GenuityBuy—
Jul 30, 2026CitizensMarket Outperform—
Jul 30, 2026HC Wainwright & Co.Buy—
Apr 29, 2026Wells FargoOverweight—
Apr 29, 2026CitizensMarket Outperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 15, 2026

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

ALACHUA, Fla. and TAMPA, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the second quarter of 2026 on Wednesday, July 29, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release. Investors interested in participating in the con

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By